SLC1A5 and SLC3A2/SLC7A5 are also crucial for the metabolism, growth, and proliferation of cancer cells. Inhibiting these transporters can reduce amino acid consumption in TME, thereby increasing amino acid availability. The gene discussed is SLC3A2; the disease is cancer.